Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
2 participants
INTERVENTIONAL
2020-06-26
2022-11-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Determination of COVID-19 Related Virus in Central Nervous System
NCT04775784
Imaging SARS-CoV-2 Involvement of Leptomeninges, Olfactory and Limbic Areas
NCT04448054
Neurodegeneration Markers and Neurological Course in Severe Covid-19 Infection
NCT04361344
COVID-19 Brain Injury
NCT04496076
Exploring Brain Damages After COVID-19 Infection
NCT04405986
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Neurological biological samples
Cerebrospinal fluid sampling, meningeal and brain parenchyma biopsies
Cerebrospinal fluid sampling, meningeal and brain parenchyma biopsies
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cerebrospinal fluid sampling, meningeal and brain parenchyma biopsies
Cerebrospinal fluid sampling, meningeal and brain parenchyma biopsies
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fondation Ophtalmologique Adolphe de Rothschild
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pierre BOURDILLON, MD
Role: PRINCIPAL_INVESTIGATOR
Fondation A. de Rothschild
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fondation A de Rothschild
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PBN_2020_16
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.